Tanaka Mari, Uppot Raul, Daye Dania, Liu Raymond, Wehrenberg-Klee Eric
Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
CVIR Endovasc. 2023 Feb 7;6(1):3. doi: 10.1186/s42155-023-00349-y.
During catheter directed intraarterial therapy for liver lesions, challenging hepatic vascular anatomy can sometimes prevent selective administration of treatment delivery to liver tumors leading to increased toxicity to normal liver parenchyma. The objective of this study is to describe a variation of the double balloon technique that isolates the feeding artery to liver tumors proximally and distally to provide treatment delivery in lesions that cannot be otherwise selected.
An IRB-approved retrospective review of 7 patients who had undergone either radioembolization, chemoembolization, or bland embolization and the double balloon technique was employed. The devices used for flow augmentation were two 2.1 French balloon microcatheters (Sniper™, Embolx). One balloon was inflated distal to target vessel and the second was inflated proximal to protect from reflux.
DEB-TACE was performed in 3 cases, Y was performed in 4, and bland embolization was performed in the last patient. There were no adverse effects from the procedure or clinically evident effects from non-target embolization. Mean follow up time was 286.4 +/- 200.1 days. Six of the 7 patients are alive. One patient passed away on post-procedure day 121 from septic shock unrelated to the procedure. One patient was bridged to transplant with an additional TACE of a separate lesion.
Double-balloon technique for patients undergoing Y or chemoembolization is a safe adjunctive technique for super selective treatment of hepatic lesions where direct selection via catheter is not feasible. This may increase the range of lesions that can be both safely and effectively treated by catheter directed therapies.
在经导管肝内病变动脉介入治疗过程中,复杂的肝血管解剖结构有时会妨碍对肝肿瘤进行选择性治疗,导致对正常肝实质的毒性增加。本研究的目的是描述一种双球囊技术的变体,该技术可在肝肿瘤供血动脉的近端和远端进行隔离,以便在无法进行其他选择性治疗的病变中进行治疗。
对7例接受过放射性栓塞、化学栓塞或单纯栓塞并采用双球囊技术的患者进行了一项经机构审查委员会批准的回顾性研究。用于增加血流量的装置是两根2.1法国规格的球囊微导管(Sniper™,Embolx)。一个球囊在靶血管远端充气,另一个在近端充气以防止反流。
3例患者接受了载药微球经动脉化疗栓塞(DEB-TACE),4例患者接受了钇-90微球选择性体内放射治疗(Y),最后1例患者接受了单纯栓塞。该操作没有产生不良反应,也没有非靶栓塞的临床明显影响。平均随访时间为286.4±200.1天。7例患者中有6例存活。1例患者在术后第121天因与手术无关的感染性休克死亡。1例患者在接受另一个单独病变的经动脉化疗栓塞(TACE)后过渡到肝移植。
对于接受Y或化学栓塞的患者,双球囊技术是一种安全的辅助技术,用于超选择性治疗无法通过导管直接选择的肝病变。这可能会扩大导管介入治疗能够安全有效治疗的病变范围。